156 Participants Needed

Exercise for Chronic Kidney Disease

Recruiting at 1 trial location
DD
JP
Overseen ByJeanie Park, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial requires that you stop taking certain medications, such as central α-agonists (like clonidine) and immunosuppressive medications (like steroids and biologics). If you are on these medications, you may need to discuss alternatives with your doctor.

What data supports the effectiveness of exercise as a treatment for chronic kidney disease?

Research shows that exercise can improve physical function, fitness, and quality of life in people with chronic kidney disease. It may also help with blood pressure control and mental health, although more studies are needed to confirm these benefits.12345

Is exercise safe for people with chronic kidney disease?

Exercise is generally considered safe for people with chronic kidney disease, including those on dialysis, with no reports of serious injury. However, some common minor issues like low blood pressure and muscle cramps have been noted during exercise sessions.46789

How is the exercise treatment for chronic kidney disease different from other treatments?

Exercise treatment for chronic kidney disease is unique because it focuses on improving physical function and quality of life through physical activity, rather than using medication. It aims to enhance cardiovascular health, muscle strength, and overall well-being, which are often neglected in standard care for CKD patients.3491011

What is the purpose of this trial?

This trial aims to help people with chronic kidney disease improve their ability to exercise. It uses regular physical activity and a substance similar to baking soda to make it easier for their muscles to get enough blood during exercise.

Research Team

JP

Jeanie Park, MD

Principal Investigator

Emory University

Eligibility Criteria

This trial is for sedentary adults with stable chronic kidney disease (CKD) or healthy individuals as controls. CKD participants should have a steady kidney function, normal serum bicarbonate levels, and may have hypertension. Excluded are those with severe obesity, uncontrolled high blood pressure, recent surgery, pregnancy plans, certain heart conditions or metal implants that affect MRI scanning.

Inclusion Criteria

I either have chronic kidney disease or I do not have any kidney disease.
You don't regularly exercise, meaning you exercise for less than 20 minutes, twice a week.
My kidney function is stable and my blood's bicarbonate level is within the normal range.
See 1 more

Exclusion Criteria

You have a condition called metabolic alkalosis.
Your blood has low levels of hemoglobin, which is less than 10 grams per deciliter.
My BMI is over 40.
See 21 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Baseline measurements in healthy participants without CKD will be measured and compared to participants with CKD

1 week
1 visit (in-person)

Treatment

Participants with CKD undergo exercise training for 20-45 minutes, 3 times per week, for 12 weeks, with either sodium bicarbonate or placebo

12 weeks
36 visits (in-person)

Follow-up

Participants are monitored for changes in exercise capacity, MSNA, IL-6, blood pressure, T2water, lean body mass, and exercise pressor reflex

4 weeks

Treatment Details

Interventions

  • Exercise Training
  • Placebo
  • Sodium Bicarbonate
Trial Overview The study explores how exercise affects people with CKD compared to healthy controls. It tests whether exercise training or sodium bicarbonate supplementation can improve the body's response to physical activity in CKD patients versus a placebo group.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Exercise Training plus Sodium BicarbonateExperimental Treatment2 Interventions
Participants with CKD will undergo exercise training for 20-45 minutes, 3 times per week, for 12 weeks. Additionally, participants take 650-1300 mg of sodium bicarbonate twice daily.
Group II: Exercise Training plus PlaceboActive Control2 Interventions
Participants with CKD will undergo exercise training for 20-45 minutes, 3 times per week, for 12 weeks. Additionally, participants take placebo tablets to match 650-1300 mg of sodium bicarbonate twice daily.
Group III: Healthy controlActive Control1 Intervention
Baseline measurements in healthy participants without CKD will be measured and compared to participants with CKD. Healthy controls will not receive any interventions.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

A 10-week exercise rehabilitation program for individuals with chronic kidney disease (CKD) did not show a significant difference in physical function improvement after one year compared to nonattenders and a control group, indicating the need for further research on long-term effectiveness.
However, participants who attended the program were more likely to maintain regular exercise habits after one year, suggesting potential benefits in promoting sustained physical activity among CKD patients.
Effect of an exercise rehabilitation program on physical function over 1 year in chronic kidney disease: an observational study.Hargrove, N., Tays, Q., Storsley, L., et al.[2022]
Exercise training has been shown to significantly improve physical function, fitness, and quality of life in individuals with chronic kidney disease, yet it is not commonly included in standard kidney care programs.
To integrate exercise rehabilitation into kidney care, it is essential to focus on clinically relevant outcomes for patients, implement evidence-based strategies, and treat exercise as a legitimate medical therapy.
Advancing Exercise Science for Better Health Outcomes Across the Spectrum of Chronic Kidney Disease.Bohm, C., Bennett, P., Lambert, K., et al.[2023]
Chronic kidney disease (CKD) significantly increases the risk of cardiovascular disease (CVD), which is a leading cause of health issues and death in CKD patients, highlighting the need for effective management strategies.
Research is focusing on exercise rehabilitation as a potential intervention to improve physical function, reduce CVD risk, and enhance quality of life for individuals with CKD, aiming to understand the mechanisms behind these benefits.
Exercise therapy in individuals with chronic kidney disease: a systematic review and synthesis of the research evidence.Koufaki, P., Greenwood, SA., Macdougall, IC., et al.[2018]

References

Effect of an exercise rehabilitation program on physical function over 1 year in chronic kidney disease: an observational study. [2022]
Advancing Exercise Science for Better Health Outcomes Across the Spectrum of Chronic Kidney Disease. [2023]
Exercise therapy in individuals with chronic kidney disease: a systematic review and synthesis of the research evidence. [2018]
Exercise and chronic kidney disease: current recommendations. [2022]
The physical deterioration of dialysis patients-Ignored, ill-reported, and ill-treated. [2018]
Exercise in the end-stage renal disease population. [2022]
Exercise training during hemodialysis in Brazil: A national survey. [2022]
Exercise training in patients after kidney transplantation. [2021]
Exercise training in CKD: efficacy, adherence, and safety. [2022]
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet? [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Implementing exercise: what do we know? Where do we go? [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security